AFG
ABBV icon

Argent Financial Group’s AbbVie ABBV Stock Holding History

Argent Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$18.8M Buy
+95,156
New +$17.8M 2.23% 4

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Argent Financial Group's ABBV Position: Q3 2024 in Review

Argent Financial Group opened a new position in AbbVie (ABBV) in Q3 2024: 95,156 shares worth $18.8M. The stake represents 2.23% of the portfolio and ranks #4 among its holdings.

3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Argent Financial Group held 95,156 shares of AbbVie worth $18.8M as of Q3 2024.
  • AbbVie was a new Argent Financial Group position in Q3 2024.
  • AbbVie made up 2.23% of Argent Financial Group's portfolio in Q3 2024, its #4 holding.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Argent Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.